Market Tracker

05/24 5:16pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

120.75
Delayed Data
As of May 24
 +1.45 / +1.22%
Today’s Change
71.63
Today|||52-Week Range
131.84
+11.37%
Year-to-Date

Today’s Trading

Previous close119.30
Today’s open119.84
Day’s range119.08 - 121.29
Volume326,217
Average volume (3 months)430,254
Market cap$2.5B
Dividend yield--
Data as of 4:00pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+2,064.46%
Earnings growth (this year)+2.00%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+11.43%
P/E ratio10.0
Price/Sales32.00
Price/Book7.82

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC+0.14+0.92%
RAREUltragenyx Pharmaceu...+3.09+4.74%
MYGNMyriad Genetics Inc+0.51+1.49%
MDCOMedicines Co+0.78+2.14%
Data as of 4:00pm ET, 05/24/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)$0.56
Annual revenue (last year)$71.9M
Annual profit (last year)$257.3M
Net profit margin357.80%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts